Stocks TelegraphStocks Telegraph
Stock Ideas

IBIO Financial Statements and Analysis

NASDAQ : IBIO

iBio

$1.56
0.01+0.65%
At Close 4:00 PM
62.21
BESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202620252025
periodQ3Q2Q1Q4Q3
revenue00100.00K200.00K0
cost of revenue0241.00K289.00K00
gross profit0-241.00K-189.00K200.00K0
gross profit ratio00-1.891.000
research and development expenses3.254M4.28M3.55M3.224M1.906M
general and administrative expenses5.111M5.165M2.501M2.174M2.973M
selling and marketing expenses00000
selling general and administrative expenses5.111M5.165M2.501M2.174M2.973M
other expenses0-2.741M-289.00K00
operating expenses8.365M6.704M5.762M5.398M4.879M
cost and expenses06.945M6.051M5.398M4.879M
interest income657.00K493.00K267.00K79.00K72.00K
interest expense-22.00K41.00K36.00K44.00K54.00K
depreciation and amortization0241.00K289.00K285.00K282.00K
ebitda0-6.704M-5.395M-4.834M-4.525M
ebitda ratio00-53.95-24.170
operating income0-6.945M-5.951M-5.198M-4.879M
operating income ratio00-59.51-25.990
total other income expenses net0-2.048M231.00K35.00K18.00K
income before tax-7.73M-8.993M-5.72M-5.163M-4.861M
income before tax ratio00-57.20-25.8150
income tax expense00000
net income-7.73M-8.993M-5.72M-5.163M-4.861M
net income ratio00-57.20-25.8150
eps-0.06-0.091-0.11-0.31-0.49
eps diluted-0.06-0.091-0.11-0.31-0.49
weighted average shs out119.60M99.133M52.981M16.424M9.862M
weighted average shs out dil119.60M99.133M52.981M16.424M9.862M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202620252025
periodQ3Q2Q1Q4Q3
cash and cash equivalents47.631M28.672M28.111M8.582M4.959M
short term investments024.026M21.456M00
cash and short term investments47.631M52.698M49.567M8.582M4.959M
net receivables0065.00K105.00K0
inventory00000
other current assets29.62M670.00K1.14M1.034M1.101M
total current assets77.251M53.368M50.772M9.721M6.06M
property plant equipment net5.076M5.311M5.168M5.282M5.562M
goodwill00000
intangible assets1.83M4.338M6.843M6.848M6.103M
goodwill and intangible assets1.83M4.338M6.843M6.848M6.103M
long term investments01.366M1.346M1.308M0
tax assets00000
other non current assets1.677M10.00K26.00K26.00K1.378M
total non current assets8.583M11.025M13.383M13.464M13.043M
other assets00000
total assets85.834M64.393M64.155M23.185M19.103M
account payables3.035M2.654M2.822M2.188M1.477M
short term debt532.00K518.00K1.21M1.309M1.43M
tax payables00000
deferred revenue01.15M1.15M1.20M600.00K
other current liabilities2.937M1.579M850.00K1.409M1.89M
total current liabilities6.504M5.901M6.048M6.106M5.397M
long term debt1.793M1.932M2.068M2.199M2.325M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities1.793M1.932M2.068M2.199M2.325M
other liabilities00000
capital lease obligations2.325M2.45M2.572M2.742M2.931M
total liabilities8.297M7.833M8.116M8.305M7.722M
preferred stock00000
common stock35.00K30.00K20.00K19.00K10.00K
retained earnings-354.667M-346.937M-337.944M-332.224M-327.061M
accumulated other comprehensive income loss-21.00K10.00K-15.00K00
other total stockholders equity432.19M403.457M393.978M347.085M338.432M
total stockholders equity77.537M56.56M56.039M14.88M11.381M
total equity77.537M56.56M56.039M14.88M11.381M
total liabilities and stockholders equity85.834M64.393M64.155M23.185M19.103M
minority interest00000
total investments025.392M22.802M1.308M0
total debt2.325M2.45M3.294M3.508M3.755M
net debt-45.306M-26.222M-24.817M-5.074M-1.204M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
reported currencyUSDUSDUSDUSDUSD
calendar year20262026202620252025
periodQ3Q2Q1Q4Q3
deferred income tax00000
stock based compensation377.00K253.00K323.00K270.00K370.00K
change in working capital-263.00K792.00K-529.00K8.00K1.118M
accounts receivables00-65.00K00
inventory00000
accounts payables380.00K-29.00K495.00K712.00K863.00K
other working capital0821.00K-959.00K-704.00K255.00K
other non cash items1.527M2.918M-28.00K-15.00K-14.00K
net cash provided by operating activities-6.084M-5.241M-5.665M-4.615M-3.105M
investments in property plant and equipment-11.00K-516.00K-32.00K-1.00K-14.00K
acquisitions net00000
purchases of investments12.961M-23.928M-21.461M00
sales maturities of investments00000
other investing activites-16.061M21.461M046.00K0
net cash used for investing activites-3.111M-2.983M-21.493M45.00K-14.00K
debt repayment0-614.00K-160.00K-183.00K-176.00K
common stock issued-52.63M9.399M46.76M2.41M1.127M
common stock repurchased00000
dividends paid00000
other financing activites28.154M0105.00K5.953M112.00K
net cash used provided by financing activities28.154M8.785M46.705M8.18M1.063M
effect of forex changes on cash18.00K0-18.00K00
net change in cash0561.00K19.529M3.61M-2.056M
cash at end of period028.672M28.111M8.792M5.182M
cash at beginning of period28.672M28.111M8.582M5.182M7.238M
operating cashflow-6.084M-5.241M-5.665M-4.615M-3.105M
capital expenditure-11.00K-516.00K-32.00K-1.00K-14.00K
free cash flow-6.095M-5.757M-5.697M-4.616M-3.119M
Graph

Frequently Asked Questions

How did iBio, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, IBIO generated $0.00 in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did iBio, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. iBio, Inc. reported a $0.00 Gross Profit for the quarter ended Mar 31, 2026.
Have IBIO's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. IBIO incurred $8.37M worth of Operating Expenses, while it generated $0.00 worth of Operating Income.
How much Net Income has IBIO posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from iBio, Inc., the company generated -$7.73M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did iBio, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to iBio, Inc. as of the end of the last quarter was $47.63M.
What are IBIO's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, IBIO had Total Net Receivables of $0.00.
In terms of Total Assets and Current Assets, where did iBio, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of IBIO were $77.25M, while the Total Assets stand at $85.83M.
As of the last quarter, how much Total Debt did iBio, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of IBIO's debt was $2.33M at the end of the last quarter.
What were IBIO's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, IBIO reported total liabilities of $8.30M.
How much did IBIO's Working Capital change over the last quarter?
Working Capital Change for IBIO was -$263.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
IBIO generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. IBIO generated -$6.08M of Cash from Operating Activities during its recently reported quarter.
What was IBIO's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. IBIO reported a $0.00 Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph